Clinical Trial Update: A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the safety, immune response, and clinical efficacy of a urinary tract infection vaccine in adults, with recruiting stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infections

Drugs mentioned

• UTI vaccine candidate

Snippet

Sponsor: GlaxoSmithKline | Conditions: Urinary Tract Infections | Phase 1, Phase 2 | Status: RECRUITING